Eligible Countries

In 2000 Pfizer began a partnership with the South African Ministry of Health to donate the antifungal Diflucan® through government hospitals to patients lacking even the most basic health care. Based on the initial success in reaching patients, the South African partnership was expanded and became the Diflucan® Partnership Program.

Over 66 million tablets have been shipped to clinics and governments since the program’s outset. Governmental and nongovernmental organizations in developing countries with HIV/AIDS prevalence of greater than 1 percent are given priority. The following countries are eligible for the program:

Afghanistan Malawi
Angola Maldives
Argentina Mali
Bangladesh Mauritania
Barbados Mozambique
Belize Myanmar
Benin Namibia
Bhutan Nepal
Botswana Niger
Burkina Faso Nigeria
Burundi Panama
Cambodia Papua New Guinea
Cameroon Paraguay
Cape Verde Peru
Central African Republic Rwanda
Chad Samoa
Colombia São Tomé and Príncipe
Comoros Senegal
Congo Seychelles
Costa Rica Sierra Leone
Côte d’Ivoire Solomon Islands
Democratic Republic of Congo Somalia
Djibouti South Africa
Dominican Republic Sudan
El Salvador Suriname
Equatorial Guinea Swaziland
Eritrea Tanzania
Ethiopia Thailand
Gabon Togo
Gambia Trinidad and Tobago
Ghana Tuvalu
Guatemala Uganda
Guinea Ukraine
Guinea-Bissau Vanuatu
Guyana Venezuela
Haiti Yemen
Honduras Zambia
Jamaica Zimbabwe
Kenya
Laos
Lesotho
Liberia
Madagascar

Twitter

Contact & Copyright

© 2001-2013 Direct Relief. All rights reserved.
Direct Relief is a registered 501(c)(3) organization.
Direct Relief
27 S. La Patera Lane
Santa Barbara, CA 93117
Phone: (805) 964-4767
Fax: (805) 681-4838
Federal Tax ID number: 95-1831116
Email & Contact Form
Privacy Policy | Donation Policy

Awards & Recognition